» Articles » PMID: 37705037

The METS-IR is Independently Related to Bone Mineral Density, FRAX Score, and Bone Fracture Among U.S. Non-diabetic Adults: a Cross-sectional Study Based on NHANES

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2023 Sep 13
PMID 37705037
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The purpose of this study was to investigate the association between the metabolic score for insulin resistance (METS-IR) and bone mineral density (BMD) in American non-diabetic adults.

Methods: We conducted a cross-sectional study with 1114 non-diabetic adults from the National Health and Nutrition Examination Survey cycle (2013-2014). The associations between METS-IR and BMD of total femur and spine were assessed by the multiple linear regression and verified the non-linear relationship with a smooth curve fit and threshold effect model. Furthermore, we evaluated the relationship between METS-IR, FRAX score, and history of bone fractures.

Results: We found that BMD of the total femur and spine increased by 0.005 g/cm and 0.005 g/cm, respectively, for a one-unit increase of METS-IR in all participants. This positive association was more pronounced among higher METS-IR participants, and there was a non-linear relationship, which was more significant when the MTTS-IR was < 41.62 or the METS-IR was < 41.39 (β = 0.008, β = 0.011, all P < 0.05). We also found that METS-IR was positively correlated with both FRAX scores in all female participants. However, METS-IR was positively correlated only with the 10-year hip fracture risk score in male participants with fractures. No significant association between METS-IR and a history of bone fractures.

Conclusions: In American non-diabetic adults, there is a correlation between elevated levels of METS-IR within the lower range and increased BMD as well as decreased risk of fractures, suggesting that METS-IR holds promise as a novel biomarker for guiding osteoporosis (OP) prevention. However, it is important to carefully balance the potential benefits and risks of METS-IR in OP.

Citing Articles

Insulin Resistance and Bone Mineral Density: A Comprehensive Examination Using UK Biobank Data.

Hung Y, Yu T, Alizargar J Healthcare (Basel). 2025; 12(24.

PMID: 39765929 PMC: 11727659. DOI: 10.3390/healthcare12242502.


A systematic review of the association between insulin resistance surrogate indices and bone mineral density.

Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri S Front Endocrinol (Lausanne). 2025; 15:1499479.

PMID: 39744182 PMC: 11688183. DOI: 10.3389/fendo.2024.1499479.


Potassium Intake and Bone Health: A Narrative Review.

Abate V, Vergatti A, Altavilla N, Garofano F, Salcuni A, Rendina D Nutrients. 2024; 16(17).

PMID: 39275337 PMC: 11397259. DOI: 10.3390/nu16173016.


Impact of metabolic syndrome on bone mineral density in men over 50 and postmenopausal women according to U.S. survey results.

Tan M, Zhu S, Wang G, Liu Z Sci Rep. 2024; 14(1):7005.

PMID: 38523143 PMC: 10961310. DOI: 10.1038/s41598-024-57352-z.

References
1.
Zhang M, Liu D, Qin P, Liu Y, Sun X, Li H . Association of metabolic score for insulin resistance and its 6-year change with incident type 2 diabetes mellitus. J Diabetes. 2021; 13(9):725-734. DOI: 10.1111/1753-0407.13161. View

2.
Han H, Chen S, Wang X, Jin J, Li X, Li Z . Association between muscle strength and mass and bone mineral density in the US general population: data from NHANES 1999-2002. J Orthop Surg Res. 2023; 18(1):397. PMC: 10233893. DOI: 10.1186/s13018-023-03877-4. View

3.
Ackert-Bicknell C . HDL cholesterol and bone mineral density: is there a genetic link?. Bone. 2011; 50(2):525-33. PMC: 3236254. DOI: 10.1016/j.bone.2011.07.002. View

4.
Cao J . Effects of obesity on bone metabolism. J Orthop Surg Res. 2011; 6:30. PMC: 3141563. DOI: 10.1186/1749-799X-6-30. View

5.
Botushanov N, Orbetzova M . Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med (Plovdiv). 2010; 51(4):12-7. View